AzTrials
AzTrials

Perioperative Respiratory FunctionNCT07067684

LTV (Low Tidal Volüme) Ventilation and Diaphragmatic Motion in CABG (Coronary Artery Bypass Grafting)

A study testing Low Tidal Volume Ventilation During CPB in people with Perioperative Respiratory Function and Diaphragmatic Dysfunction, run by Konya City Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate whether low tidal volume (LTV) ventilation during cardiopulmonary bypass (CPB) surgery helps preserve diaphragmatic excursion in adult patients undergoing coronary artery bypass grafting (CABG). Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Low Tidal Volume Ventilation During CPB
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2025to 30 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age over 18 years
  • Male or female patients
  • American Society of Anesthesiologists (ASA) physical status class II or III
  • Scheduled for elective coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB)
  • Provided written informed consent to participate in the study -

Who cannot join

  • History of neuromuscular disease
  • History of thoracic surgery
  • History of pneumothorax or ascites
  • Chronic respiratory failure
  • Pulmonary hypertension or right ventricular failure
  • Emergency surgery
Show all 9Show fewer
  • Inability to perform diaphragm ultrasonographic measurements
  • Refusal to participate in the study
  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Konya City Hospital

    Konya, Konya, 42020

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Low Tidal Volume Ventilation on Diaphragmatic Excursion in Cardiopulmonary Bypass Surgery

The goal of this clinical trial is to evaluate whether low tidal volume (LTV) ventilation during cardiopulmonary bypass (CPB) surgery helps preserve diaphragmatic excursion in adult patients undergoing coronary artery bypass grafting (CABG). The study will also assess the relationship between LTV ventilation and postoperative pulmonary complications, such as atelectasis, pleural effusion, and pneumonia.

The main questions this trial aims to answer are:

Read more

Does LTV ventilation better preserve diaphragmatic motion compared to apnea during CPB?

Are postoperative pulmonary complications less frequent in patients receiving LTV?

Does LTV contribute to shorter extubation times and ICU stays?

Researchers will compare LTV ventilation with apnea (standard care) during CPB to assess its effects on diaphragmatic excursion, measured via ultrasound, and postoperative respiratory outcomes.

Participants will:

Undergo elective CABG surgery under general anesthesia

Be randomly assigned to receive either LTV ventilation or apnea during CPB

Have diaphragmatic excursion measured by ultrasound before surgery, before extubation, and 24 hours after surgery

Be monitored for postoperative pulmonary complications (atelectasis, effusion, pneumonia), extubation time, and ICU length of stay

Ultrasound will be used to measure diaphragmatic excursion (DE) in quiet and deep breathing. DE below 10 mm will be considered as diaphragmatic paralysis. Postoperative respiratory assessments will include blood gas analysis (PaO₂/FiO₂ ratio), clinical respiratory parameters, and imaging findings.

This is a prospective, single-center, assessor-blinded randomized controlled trial. Patients and outcome assessors will be blinded to group allocation. The study will be conducted at the Anesthesiology Clinic of Konya City Hospital and is expected to enroll 60 patients.

Read the detailed description

oronary artery bypass grafting (CABG) surgery performed under cardiopulmonary bypass (CPB) is a complex procedure frequently associated with postoperative pulmonary complications (PPCs). During CPB, mechanical ventilation is usually paused (apnea), which leads to temporary diaphragmatic inactivity. The diaphragm, being a rhythmically contracting muscle under normal physiological conditions, may experience transient dysfunction or even paralysis due to this intraoperative inactivity. Several mechanisms, including loss of neuromechanical coupling, disrupted neuromuscular signaling, altered venous return, and impaired diaphragmatic oxygenation and metabolism, are thought to contribute to this process.

Reduced diaphragmatic motion can create a favorable condition for atelectasis, impair oxygenation, and increase the risk of infection in the postoperative period. The resulting transient diaphragmatic dysfunction is considered a potential contributor to the development of PPCs such as pneumonia, pleural effusion, and prolonged mechanical ventilation.

Recent research has focused on the protective effects of low tidal volume (LTV) ventilation in surgical and critical care settings. However, limited studies have evaluated its direct impact on diaphragmatic function during CPB, particularly in the context of CABG surgery. There is a need to investigate whether intraoperative application of LTV ventilation during CPB can help preserve diaphragmatic excursion (DE) and reduce PPCs.

Being tested
Low Tidal Volume Ventilation During CPB
Keywords
Low Tidal Volume Ventilation, Diaphragmatic Excursion, Coronary Artery Bypass Grafting (CABG)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low Tidal Volume Ventilation During CPBOther

    Group Low: Patients in this group will receive low tidal volume mechanical ventilation during cardiopulmonary bypass (CPB).

    Ventilation settings will be:

    Tidal Volume: 3-4 mL/kg (ideal body weight)

    PEEP: 5-8 cmH₂O

    Respiratory Rate: adjusted to maintain normocapnia (PaCO₂ 35-45 mmHg)

Study groups in NCT07067684
Study groupRoleWhat they receive
Group LowExperimentalLow Tidal Volume Ventilation Group (LTV)
Receives: Other: Low Tidal Volume Ventilation During CPB
Group ApneaNo interventionApnea Group (Control Group)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Diaphragmatic Excursion Measured by Ultrasound

    Diaphragmatic excursion (DE) will be measured using M-mode ultrasonography with a 2-5 MHz convex probe placed in the right mid-clavicular subcostal view. Measurements will be performed during both quiet and deep breathing maneuvers. A DE value of ≤10 mm will be considered indicative of diaphragmatic paralysis. The average of three consecutive measurements will be recorded at each time point. The main comparison will assess postoperative DE values between groups receiving low tidal volume ventilation and apnea during CPB.

    Measured: Baseline (30 minutes before transfer to the operating room (Preoperative baseline) Postoperative ( Immediately Before Extubation) 24 Hours After Surgery (24 hours after the end of surgery)

Secondary outcomes (2)
  1. Incidence of Postoperative Pulmonary Complications

    Measured: First 3 Days After Surgery and Prior to ICU Discharge

  2. Time to Extubation

    The time from ICU admission to successful extubation will be recorded in hours. Extubation will be performed based on predefined weaning criteria, including neurological status, respiratory stability, hemodynamic parameters, and oxygenation status. Patients not meeting criteria within 24 hours will be recorded accordingly.

    Measured: From ICU Admission to Extubation (Up to 24 Hours Postoperatively)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2025
  2. Study start1 Jul 2025
  3. Primary completion5 Nov 2025
  4. Study completion30 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized, controlled, parallel-assignment trial with an assessor-blinded design.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07067684
Sponsor's protocol ID
Diaflex
Status last verified
Sep 2026
First submitted
2 Jul 2025
Last updated
15 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The plan to share individual participant data has not been determined. No data will be shared at this stage due to institutional policy and ethical concerns.

Publications

  • Barbariol F, Deana C, Guadagnin GM, Cammarota G, Vetrugno L, Bassi F. Ultrasound diaphragmatic excursion during non-invasive ventilation in ICU: a prospective observational study. Acta Biomed. 2021 Jul 1;92(3):e2021269. doi: 10.23750/abm.v92i3.11609.

    PubMed 34212900

Questions about this trial

What is this clinical trial studying?

A study testing Low Tidal Volume Ventilation During CPB in people with Perioperative Respiratory Function and Diaphragmatic Dysfunction, run by Konya City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Diaphragmatic Excursion Measured by Ultrasound (time frame: Baseline (30 minutes before transfer to the operating room (Preoperative baseline) Postoperative ( Immediately Before Extubation) 24 Hours After Surgery (24 hours after the end of surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07067684, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in